Safety and Efficacy of the Xanomeline Transdermal Therapeutic System (TTS) in Patients with Mild to Moderate Alzheimers Disease. · Phase II
718 (USA) · Dr. Nolan
consented 2012-12-17
Adverse events
Mild AMNESIA — outcome: NOT RECOVERED/NOT RESOLVED; onset 2013-01-01 (study day 16.0); relationship: NONE
Mild AMNESIA — outcome: RECOVERED/RESOLVED; onset 2013-01-01 (study day 16.0); relationship: NONE
Moderate APPLICATION SITE DERMATITIS — outcome: RECOVERED/RESOLVED; onset 2013-01-27 (study day 42.0); relationship: PROBABLE
Mild APPLICATION SITE DERMATITIS — outcome: NOT RECOVERED/NOT RESOLVED; onset 2013-01-29 (study day 44.0); relationship: PROBABLE
Moderate APPLICATION SITE PRURITUS — outcome: NOT RECOVERED/NOT RESOLVED; onset 2013-01-27 (study day 42.0); relationship: PROBABLE
Moderate APPLICATION SITE PRURITUS — outcome: RECOVERED/RESOLVED; onset 2013-01-27 (study day 42.0); relationship: PROBABLE
Mild BACK PAIN — outcome: RECOVERED/RESOLVED; onset 2012-12-18 (study day 2.0); relationship: NONE
Moderate DECREASED APPETITE — outcome: NOT RECOVERED/NOT RESOLVED; onset 2013-02-04 (study day 50.0); relationship: POSSIBLE
Moderate DECREASED APPETITE — outcome: RECOVERED/RESOLVED; onset 2013-02-04 (study day 50.0); relationship: POSSIBLE
Moderate LETHARGY — outcome: RECOVERED/RESOLVED; onset 2013-01-05 (study day 20.0); relationship: POSSIBLE
Moderate NAUSEA — outcome: RECOVERED/RESOLVED; onset 2012-12-26 (study day 10.0); relationship: REMOTE
Moderate NAUSEA — outcome: RECOVERED/RESOLVED; onset 2013-01-03 (study day 18.0); relationship: POSSIBLE
Moderate NAUSEA — outcome: RECOVERED/RESOLVED; onset 2013-01-16 (study day 31.0); relationship: POSSIBLE
Severe NAUSEA — outcome: RECOVERED/RESOLVED; onset 2013-01-21 (study day 36.0); relationship: PROBABLE
Moderate NAUSEA — outcome: NOT RECOVERED/NOT RESOLVED; onset 2013-02-04 (study day 50.0); relationship: POSSIBLE
Moderate NAUSEA — outcome: RECOVERED/RESOLVED; onset 2013-02-04 (study day 50.0); relationship: POSSIBLE
Data queries
No data queries.